Published in Diabetes Res on January 01, 1993
Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet (1982) 6.93
Patients evaluate their hospital care: a national survey. Health Aff (Millwood) (1991) 5.44
NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia (1997) 4.88
Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J (1970) 4.31
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Successful treatment of middle aged and elderly patients with end stage renal disease. Br Med J (Clin Res Ed) (1983) 2.88
Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes. N Engl J Med (1979) 2.87
Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest (1974) 2.81
10 years' experience with regular haemodialysis and renal transplantation. Arch Dis Child (1980) 2.56
Adjusting for patient characteristics when analyzing reports from patients about hospital care. Med Care (2001) 2.46
Increased platelet and red cell counts, blood viscosity, and plasma cholesterol levels during heat stress, and mortality from coronary and cerebral thrombosis. Am J Med (1986) 2.44
The complement abnormalities of lipodystrophy. N Engl J Med (1976) 2.40
Gastric cancer simulating benign gastric ulcer. Br J Surg (1969) 2.27
Enumeration of petroleum-degrading microorganisms. Appl Environ Microbiol (1976) 2.09
Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J (1973) 2.07
Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function. Circulation (1997) 2.05
Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet (1973) 2.00
Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet (1993) 1.95
Measuring the potential activity of hydrocarbon-degrading bacteria. Appl Environ Microbiol (1976) 1.94
Using patient reports to improve medical care: a preliminary report from 10 hospitals. Qual Manag Health Care (1993) 1.93
Role of C3b in the breakdown of C3 in hypocomplementaemic mesangiocapillary glomerulonephritis. Lancet (1973) 1.93
Continuous subcutaneous insulin infusion in the treatment of diabetes mellitus. Diabetes Care (1980) 1.92
Microalbuminuria predicts mortality in non-insulin-dependent diabetics. Diabet Med (1984) 1.90
Some effects of petroleum on estuarine and marine microorganisms. Can J Microbiol (1975) 1.85
Winning the Stanley Cup Final Series is related to incurring fewer penalties for violent behavior. Tex Med (1999) 1.75
The conversion of testosterone to 5 alpha-androstan-17 beta-ol-3-one (dihydrotestosterone) by skin slices of man. J Clin Invest (1969) 1.75
Utilization of hydrocarbons by Cladosporium resinae. J Gen Microbiol (1973) 1.73
Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med (1983) 1.70
Studies of serum complement in the hypocomplementaemic nephritides. Clin Exp Immunol (1974) 1.67
Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes? BMJ (1993) 1.58
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study. Diabetologia (1991) 1.55
Restriction of dietary protein and progression of renal failure in diabetic nephropathy. Lancet (1989) 1.55
Murine lupus monoclonal antibodies define five epitopes on two different Sm polypeptides. Immunology (1986) 1.54
Declining incidence of multiple sclerosis in the Orkney Islands. Neurology (1985) 1.54
Gastroscopy with biopsy and cytological sampling under direct vision. Br Med J (1968) 1.53
Increased glomerular permeability to albumin induced by exercise in diabetic subjects. Diabetologia (1978) 1.51
Systematic review on urine albumin testing for early detection of diabetic complications. Health Technol Assess (2005) 1.51
Hypomagnesaemia in IDDM patients with microalbuminuria and clinical proteinuria. Diabetologia (1994) 1.50
Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function. Circ Res (1998) 1.49
Anti-ssDNA and antinuclear antibodies in human malaria. Clin Exp Immunol (1982) 1.49
Genes encoding the beta-chains of HLA-DR7 and HLA-DQw2 define major susceptibility determinants for idiopathic nephrotic syndrome. Clin Sci (Lond) (1990) 1.49
Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int (1992) 1.47
Monoclonal antibodies to the Sjögren's syndrome associated antigen SS-B (La). J Immunol Methods (1985) 1.46
Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia (1982) 1.46
Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria. Diabetes Care (1997) 1.45
Ropivacaine in neonates and infants: a population pharmacokinetic evaluation following single caudal block. Paediatr Anaesth (2004) 1.44
Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol (1990) 1.44
Serum sialic acid concentrations in Asian diabetic patients in the UK. Diabet Med (1996) 1.40
Transepithelial chemotaxis of rat peritoneal exudate cells. Br J Exp Pathol (1983) 1.40
A review of the literature on cocaine abuse in pregnancy. Nurs Res (1991) 1.40
Percutaneous transluminal renal angioplasty in patients with renal failure. Q J Med (1993) 1.39
Serum leptin concentration in moderate and severe obesity: relationship with clinical, anthropometric and metabolic factors. Int J Obes Relat Metab Disord (1999) 1.39
A man with diabetes and unexplained renal failure. Lancet (1998) 1.39
Virus infection induces redistribution and membrane localization of the nuclear antigen La (SS-B): a possible mechanism for autoimmunity. Clin Exp Immunol (1989) 1.36
Allele-specific interactions between ttg and gl1 during trichome development in Arabidopsis thaliana. Genetics (1999) 1.36
High versus "low" dose corticosteroids in recipients of cadaveric kidneys: prospective controlled trial. Br Med J (Clin Res Ed) (1983) 1.34
Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Br Med J (Clin Res Ed) (1983) 1.31
Hypocomplementaemic membranoproliferative glomerulonephritis and nephrotic syndrome associated with partial lipodystrophy of the face and trunk. Proc R Soc Med (1972) 1.31
Microalbuminuria in non-insulin-dependent diabetes: its prevalence in Indian compared with Europid patients. Br Med J (Clin Res Ed) (1988) 1.29
Monitoring glomerular function in diabetic nephropathy. A prospective study. Am J Med (1983) 1.25
Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men. Lancet (1980) 1.24
Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res (2001) 1.22
Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia (1995) 1.22
Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Clin Exp Immunol (1976) 1.22
The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol (1978) 1.21
Genesis and evolution of diabetic nephropathy. J Clin Pathol (1981) 1.21
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia (1996) 1.21
Gel-electrophoretic identification of hen brain neurotoxic esterase, labelled with tritiated di-isopropyl phosphorofluoridate. Biochem J (1981) 1.20
Predicting the biodegradation products of perfluorinated chemicals using CATABOL. SAR QSAR Environ Res (2004) 1.19
The variability of overnight urinary albumin excretion in insulin-dependent diabetic and normal subjects. Diabet Med (1987) 1.19
Antecedent moisture and seasonal precipitation influence the response of canopy-scale carbon and water exchange to rainfall pulses in a semi-arid grassland. New Phytol (2006) 1.18
Dianthins, ribosome-damaging proteins with anti-viral properties from Dianthus caryophyllus L. (carnation). Biochem J (1981) 1.18
Adult-onset minimal change nephrotic syndrome: a long-term follow-up. Kidney Int (1986) 1.18
Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci (Lond) (1993) 1.16
Clinical and immunological evolution of oligoanuric anti-GBM nephritis treated by haemodialysis. Lancet (1986) 1.16
C3 breakdown by serum from patients with acute post-streptococcal nephritis. Lancet (1972) 1.16
Deep-sea bacteria: growth and utilization of n-hexadecane at in situ temperature and pressure. Can J Microbiol (1975) 1.15
Vasculitis affecting the kidney: presentation, histopathology and long-term outcome. Q J Med (1984) 1.15
Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. Immunology (1994) 1.15
Antibodies to La, Jo-1, nRNP and Sm detected by multi-track immunoblotting using a novel filter holder: a comparative study with counterimmunoelectrophoresis and immunodiffusion using sera from patients with systemic lupus erythematosus and Sjögren's syndrome. J Immunol Methods (1986) 1.14
Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes (Lond) (2006) 1.13
Anti-La monoclonal antibodies recognizing epitopes within the RNA-binding domain of the La protein show differential capacities to immunoprecipitate RNA-associated La protein. Eur J Biochem (1995) 1.13
Urinary excretion of albumin in normal man: the effect of water loading. Scand J Clin Lab Invest (1982) 1.13
Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ (1989) 1.13
Bacterial degradation of motor oil. J Water Pollut Control Fed (1975) 1.13
Carepartner experiences with hospital care. Med Care (1999) 1.12
Systemic lupus with nephritis: a long-term study. Q J Med (1979) 1.11
DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus. Clin Exp Immunol (1981) 1.11
Microbial petroleum degradation: application of computerized mass spectrometry. Can J Microbiol (1975) 1.09
Evaluation of petroleum-degrading potential of bacteria from water and sediment. Appl Microbiol (1975) 1.08
Prototheca ecology. Mycopathologia (1983) 1.08
The effect of excess dietary iodine on pregnant mares and foals. Vet Rec (1975) 1.08
Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Kidney Int (1982) 1.07
Proteinuria in diabetes. Diabetologia (1983) 1.07
Metabolism of the third component of complement (C3) in normal human subjects. Clin Sci Mol Med (1974) 1.07
Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes (2000) 1.07
Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients. Lancet (1985) 1.07